143 related articles for article (PubMed ID: 26050649)
1. BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4.
Morita K; Masamoto Y; Kataoka K; Koya J; Kagoya Y; Yashiroda H; Sato T; Murata S; Kurokawa M
Leukemia; 2015 Nov; 29(11):2248-56. PubMed ID: 26050649
[TBL] [Abstract][Full Text] [Related]
2. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
6. shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells.
Xu B; Chen G; Shi P; Guo X; Xiao P; Wang W; Zhou S
Hematology; 2012 Jan; 17(1):35-40. PubMed ID: 22549446
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells.
Yang Y; Goldstein BG; Nakagawa H; Katz JP
FASEB J; 2007 Feb; 21(2):543-50. PubMed ID: 17158781
[TBL] [Abstract][Full Text] [Related]
8. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
9. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
Eisfeld AK; Schwind S; Patel R; Huang X; Santhanam R; Walker CJ; Markowitz J; Hoag KW; Jarvinen TM; Leffel B; Perrotti D; Carson WE; Marcucci G; Bloomfield CD; de la Chapelle A
Sci Signal; 2014 Apr; 7(321):ra36. PubMed ID: 24736457
[TBL] [Abstract][Full Text] [Related]
10. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
11. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.
Noura M; Morita K; Kiyose H; Matsuo H; Nishinaka-Arai Y; Kurokawa M; Kamikubo Y; Adachi S
Sci Rep; 2020 Nov; 10(1):20245. PubMed ID: 33219287
[TBL] [Abstract][Full Text] [Related]
12. Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Eisfeld AK; Marcucci G; Liyanarachchi S; Döhner K; Schwind S; Maharry K; Leffel B; Döhner H; Radmacher MD; Bloomfield CD; Tanner SM; de la Chapelle A
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6668-73. PubMed ID: 22493267
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms and function of ERK MAP kinases.
Torii S; Nakayama K; Yamamoto T; Nishida E
J Biochem; 2004 Nov; 136(5):557-61. PubMed ID: 15632293
[TBL] [Abstract][Full Text] [Related]
14. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
Miranda MB; Xu H; Torchia JA; Johnson DE
Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
[TBL] [Abstract][Full Text] [Related]
16. Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.
Johnson DE
Adv Enzyme Regul; 2008; 48():98-112. PubMed ID: 18155170
[No Abstract] [Full Text] [Related]
17. Matrix-Stiffness-Regulated Inverse Expression of Krüppel-Like Factor 5 and Krüppel-Like Factor 4 in the Pathogenesis of Renal Fibrosis.
Chen WC; Lin HH; Tang MJ
Am J Pathol; 2015 Sep; 185(9):2468-81. PubMed ID: 26212907
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the ERK pathway.
Zhang H; Wu G; Chen B
Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
[TBL] [Abstract][Full Text] [Related]
19. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.
Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G
J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway.
Zhang Y; Chen HX; Zhou SY; Wang SX; Zheng K; Xu DD; Liu YT; Wang XY; Wang X; Yan HZ; Zhang L; Liu QY; Chen WQ; Wang YF
Mol Cancer; 2015 Mar; 14():56. PubMed ID: 25890196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
